Author(s):
Shreya Gupta, Prashant Kumar, Yogendra Pal, Pawan Kumar Gupta, Shiv Dev Singh, Shashi Bhooshan Tiwari
Email(s):
s.tiwari@mjpru.ac.in
DOI:
10.52711/0974-360X.2025.00576 
Address:
Shreya Gupta, Prashant Kumar, Yogendra Pal, Pawan Kumar Gupta, Shiv Dev Singh, Shashi Bhooshan Tiwari*
Department of Pharmacy, MJP Rohilkhand University, Bareilly, Uttar Pradesh, India 243006.
*Corresponding Author
Published In:
Volume - 18,
Issue - 8,
Year - 2025
ABSTRACT:
Since ancient times, Achyranthes aspera has been used for a variety of medicinal purposes, including diabetes, in diuretic condition, protecting the brain function and many more. Recent surveys have looked into the components of Achyranthes aspera and their potential health benefits. A compound called 17-pentatriacontanol found in the plants shoots has shown antifungal properties against strains like A. Carenus. Research also suggests that Achyranthes aspera may have seizure reducing properties by enhancing GABAergic neurotransmission in the brain. It has demonstrated inflammatory and anti-cancer effects, especially promising in pancreatic cancer cases where leaf extracts were found effective. The anticancer activity might be linked to inhibiting metalloproteases (MMP 1 and 2) tissue inhibitors of MMPs (TIMP 2) and angiogenic factors like VEGF A and VEGF B. Flavonoids and saponins is assumed to provide this plant the hepatoprotective property. Extensive study has been conducted in the last some decades to demonstrate the pharmacological activity of its extract. Numerous chemical components including triacontanol, nerol, eugenol, oleanoic acid, sterols, and betaine have been identified. Computational docking studies helped predicting the interaction between plant-derived molecule and specific protein targets. The docking studies of molecules from this plant help to target two mutated BRAF and NRAS genes. Utilizing in-silico tools, the plant's bioactive compounds for anti-inflammatory, antimicrobial, and anticancer applications are also evaluated. ADMET analysis further supports their drug-like properties and safety profiles. Molecular docking studies reveal that certain saponins from this plant exhibits high binding affinity for COX-2 and 5-LOX enzymes, which are key players in inflammatory pathways.
Cite this article:
Shreya Gupta, Prashant Kumar, Yogendra Pal, Pawan Kumar Gupta, Shiv Dev Singh, Shashi Bhooshan Tiwari. Unveiling the Medicinal Benefits, Contemporary Phyto-pharmacological Potentials and In- silico Studies of Achyranthes aspera. Research Journal Pharmacy and Technology. 2025;18(8):4007-3. doi: 10.52711/0974-360X.2025.00576
Cite(Electronic):
Shreya Gupta, Prashant Kumar, Yogendra Pal, Pawan Kumar Gupta, Shiv Dev Singh, Shashi Bhooshan Tiwari. Unveiling the Medicinal Benefits, Contemporary Phyto-pharmacological Potentials and In- silico Studies of Achyranthes aspera. Research Journal Pharmacy and Technology. 2025;18(8):4007-3. doi: 10.52711/0974-360X.2025.00576 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-8-79
REFERENCES:
1. World Health Organization. WHO Global Report on Traditional and Complementary Medicine. 2019. https://www.who.int/publications/i/item/978924151536
2. Fikru A, Makonnen E, Eguale T, Debella A, Mekonnen GA. Evaluation of in vivo wound healing activity of methanol extract of Achyranthes aspera L. Journal of Ethnopharmacology. 2012; 143(2): 469-74. DOI:10.1016/j.jep.2012.06.049
3. Sharma V, Chaudhary U. An overview on indigenous knowledge of Achyranthes aspera. J. Crit. Rev. 2015; 2: 7-19.
4. Singh N, Mrinal PS, Gupta VK. A review on pharmacological aspects of Achyranthes Aspera. Int J Pharmacogn Chinese Med. 2019; 3(4): 000188. DOI: 10.23880/ipcm-16000188.
5. Ruffo CK, Birnie A, Tengnäs B. Edible Wild Plants of Tanzania. 2002.
6. Singh S, Singh A, Navneet SV. Ethnobotanical and pharmacological benefits of Achyranthes aspera Linn.: An overview. Int J Pharm Sci Rev Res. 2018; 48(2): 1-7.
7. Nadkarni KM. Indian Materia. Vol. I, 21. Popular Prakashan Prakashan, Bombay.2009
8. Bhattarai, N. K. Folk Use of Plants in Veterinary Medicine in Central Nepal. 1992: 497-506.
9. Gupta RK. Medicinal and aromatic plants.Traditional and commercial uses agrotechniques biodiversity conservation. CBS Publishers and Distributors. 2010; 234: 499.
10. Singh VK, Ali ZA, Zaidi ST, Siddiqui MK. Ethnomedicinal uses of plants from Gonda District Forests of Uttar Pradesh, India.1996: 129-139
11. Anonymous.The Wealth of India-Raw Materials, Council of Scientific and Industrial Research (CSIR), New Delhi, 2007; 17-18.
12. Dey A. Achyranthes aspera L: phytochemical and pharmacological aspects. International Journal of Pharmaceutical Sciences Review and Research. 2011; 9(2): 72-82.
13. Ghimire K, Banerjee J, Gupta AK, Dahal P. Phytochemical constituents and pharmacological uses of medicinal plant Achyranthes aspera: A Review. World Journal of Pharmaceutical Research. 2015; 4(1): 470-89.
14. Misra TN, Singh RS, Pandey HS, Prasad C. An aliphatic dihydroxyketone from Achyranthes aspera. Phytochemistry. 1991; 30(6): 2076-8. DOI: 10.1016/0031-9422(91)85071-7
15. Dayal R. Essential oil constituents of Achyranthes aspera leaves. Indian Perfumer. 2007; 51(1): 33.
16. Banerji A, Chintalwar GJ, Joshi NK, Chadha MS. Isolation of ecdysterone from Indian plants. Phytochemistry. 1971; 10(9): 2225-6.DOI: 10.1016/S0031-9422(00)97227-3
17. Batta A, Rangaswami S. Crystalline chemical components of some vegetable drugs. 1973: 214-216. DOI: 10.1016/S0031-9422(00)84654-3
18. Khastgir HN, Sengupta SK, Sengupta P. The sapogenin from seeds of Achyranthes aspera Linn. Journal of the Indian Chemical Society. 1958; 35: 693-4.
19. Ali MO. Chemical Investigation of Achyranthes aspera linn. Oriental Journal of Chemistry. 1993; 9: 84.
20. Kapoor VK, Singh H. Isolation of betaine from Achyranthes aspera Linn. Indian Journal of Chemistry. 1966; 4(10): 461.
21. Rotundo L, Pyrsopoulos N. Liver injury induced by paracetamol and challenges associated with intentional and unintentional use. World Journal of Hepatology. 2020; 12(4): 125.
22. Kumar SS, Chandrika G, Mahesh K, Meghanath PV. Hepatoprotective activity of Achyranthes aspera linn against paracetamol induced toxicity. Int J Pharm Pharm Sci. 2012; 4(5): 299-302.
23. Khan N, Akhtar MS, Khan BA, de Andrade Braga V, Reich A. Antiobesity, hypolipidemic, antioxidant and hepatoprotective effects of Achyranthes aspera seed saponins in high cholesterol fed albino rats. Archives of Medical Science. 2015; 11(6): 1261-71. DOI: 10.5114/aoms.2015.56353
24. Bhosale U, Yegnanarayan R, Prachi P, Zambare M, Somani RS. Study of CNS depressant and behavioral activity of an ethanol extract of Achyranthes Aspera (Chirchita) in mouse model. Annals of Neurosciences. 2011; 18(2): 44. DOI: 10.5214/ans.0972.7531.1118204
25. Viswanatha GL, Venkataranganna MV, Prasad NB, Shylaja H. Achyranthes aspera Linn. alleviates cerebral ischemia-reperfusion-induced neurocognitive, biochemical, morphological and histological alterations in Wistar rats. Journal of Ethnopharmacology. 2019; 228: 258 DOI: 10.1016/j.jep.2018.09.018
26. Shukla K, Jain S, Patil N, Patil K, Wagh K. Analgesic activity of Hydroalcholic extract of Achyranthes aspera leaves on animal model. Asian Journal of Pharmaceutical Research. 2021; 11(4): 239-41. DOI: 10.52711/2231-5691.2021.00041
27. Barua, C. C., Talukdar, A., Begum, S. A., Lahon, L. C., Sarma, D. K., Pathak, D. C., and Borah, P. (2010). Antinociceptive activity of methanolic extract of leaves of Achyranthes aspera Linn. (Amaranthaceae) in animal models of nociception. Indian Journal of Experimental Biology, 48(8). 817–821
28. Barua CC, Talukdar A, Begum SA, Lahon LC, Sarma DK, Pathak DC, Borah P. Antinociceptive activity of methanolic extract of leaves of Achyranthes aspera Linn.(Amaranthaceae) in animal models of nociception. 2010; 48(8): 817–821
29. Sutar NG, Sutar UN, Sharma YP, Shaikh IK, Kshirsagar SS. Phytochemical investigation and pharmacological screening of leaves of Achyranthus aspera Linn. as Analgesic and antipyretic. (2008): 841-844.
30. Mehta F, Patel B, Pandya S, Ahir K, Patel S. Antinociceptive and anti-inflammatory activity of Achyranthes aspera L. extracts. Pharmacologyonline. 2009; 3: 978-85.
31. Khan MT, Ahmad K, Alvi MN. Noor-Ul-Amin, B. Mansoor, M. Asif Saeed, FZ Khan, M. Jamshaid. Pakistan Journal of Zoology. 2010; 42(1): 93-7.
32. Saravanan P, Ramasamy V, Shivakumar T. Antimicrobial activity of leaf extracts of Achyranthes aspera Linn. Asian Journal of Chemistry. 2008; 20(1): 823. DOI:10.1016/S2222-1808(13)60039-0
33. ManjulaM., IndiraV.,Dhasarathan P. Asian Journal of Microbiology, Biotechnology and Environmental Sciences. 2009; 11(2); 365-368.
34. Gawande DY, Druzhilovsky D, Gupta RC, Poroikov V, Goel RK. Anticonvulsant activity and acute neurotoxic profile of Achyranthes aspera Linn. Journal of Ethnopharmacology. 2017; 202: 97-102. DOI: 10.1016/j.jep.2017.03.018
35. Edwin S, Jarald EE, Deb L, Jain A, Kinger H, Dutt KR, Raj AA. Wound healing and antioxidant activity of Achyranthes aspera. Pharmaceutical Biology. 2008; 46(12): 824-828. DOI:10.1080/13880200802366645
36. Das AK, Bigoniya P, Verma NK, Rana AC. Gastroprotective effect of Achyranthes aspera Linn. leaf on rats. Asian Pacific Journal of Tropical Medicine. 2012; 5(3): 197-201. DOI: 10.1016/S1995-7645(12)60024-8
37. Vasudeva N, Sharma SK. Post-coital antifertility activity of Achyranthes aspera Linn. root. Journal of Ethnopharmacology. 2006; 107(2): 179-81. DOI: 10.1016/j.jep.2006.03.009
38. Nargatti P, Patil S, Wadkar K. Phytochemical Profile and Pharmacological Aspects of Achyranthes aspera Linn-An Overview. Journal of Pharmaceutical Research International. 2021; 33(34B): 187-206. DOI: 10.9734/jpri/2021/v33i34B31860
39. Pakrashi A, Bhattacharya N. Abortifacient principle of Achyranthes aspera Linn. Indian Journal of Experimental Biology. 1977; 15(10): 856-858.
40. Mukherjee H, Ojha D, Bag P, Chandel HS, Bhattacharyya S, Chatterjee TK, Mukherjee PK, Chakraborti S, Chattopadhyay D. Anti-herpes virus activities of Achyranthes aspera: an Indian ethnomedicine, and its triterpene acid. Microbiological Research. 2013; 168(4): 238-44. DOI: 10.1016/j.micres.2012.11.002
41. Subbarayan PR, Sarkar M, Impellizzeri S, Raymo F, Lokeshwar BL, Kumar P, Agarwal RP, Ardalan B. Anti-proliferative and anti-cancer properties of Achyranthes aspera: specific inhibitory activity against pancreatic cancer cells. Journal of Ethnopharmacology. 2010; 131(1): 78-82. DOI: 10.1016/j.jep.2010.06.002
42. Akhtar MS, Iqbal J. Evaluation of the hypoglycaemic effect of Achyranthes aspera in normal and alloxan-diabetic rabbits. Journal of Ethnopharmacology. 1991; 31(1): 49-57. DOI: 10.1016/0378-8741(91)90143-2
43. Vidhya R, Gandhi GR, Jothi G, Radhika J, Brindha P. Evaluation of antidiabetic potential of Achyranthes aspera Linn. on alloxan induced diabetic animals. Int J Pharm Sci. 2012; 4(5): 577-80.
44. Tahiliani P, Kar A. Achyranthes aspera elevates thyroid hormone levels and decreases hepatic lipid peroxidation in male rats. Journal of Ethnopharmacology. 2000; 71(3): 527-32. DOI: 10.1016/S0378-8741(00)00170-7
45. Malarvili T, Gomathi N. Effect of Achyranthes aspera (Linn) seeds on redox and oxidative status in plasma and selected tissues of rats fed with high doses of fructose. Biosciences and Biotechnology Research Asia. 2009; 6(2): 659-64.
46. Gayathri DS, Archanah A, Abiramasundari P, Priya V, Uma K, Abirami T. Pharmacological activities of Achyranthes aspera, an overview. Indian J Nutr Diet. 2009; 46(12): 485-90.
47. Anuja MM, Nithya RS, Swathy SS, Rajamanickam C, Indira M. Spermicidal action of a protein isolated from ethanolic root extracts of Achyranthes aspera: an in vitro study. Phytomedicine. 2011; 18(8-9): 776-82. DOI: 10.1016/j.phymed.2011.01.007
48. Paul D, Bera S, Jana D, Maiti R, Ghosh D. In vitro determination of the contraceptive spermicidal activity of a composite extract of Achyranthes aspera and Stephania hernandifolia on human semen. Contraception. 2006; 73(3): 284-8. DOI: 10.1016/j.contraception.2005.07.014
49. Subbarayan PR, Sarkar M, Rao SN, Philip S, Kumar P, Altman N,et al. Achyranthes aspera (Apamarg) leaf extract inhibits human pancreatic tumor growth in athymic mice by apoptosis. Journal of Ethnopharmacology. 2012; 142(2): 523-30. DOI: 10.1016/j.jep.2012.05.030
50. Singh RK, Verma PK, Kumar A, Kumar S, Acharya A. Achyranthes aspera L. leaf extract induced anticancer effects on Dalton's Lymphoma via regulation of PKCα signaling pathway and mitochondrial apoptosis. Journal of Ethnopharmacology. 2021; 274: 114060. DOI: 10.1016/j.jep.2021.114060
51. Chakraborty A, Brantner A, Mukainaka T, Nobukuni Y, Kuchide M, Konoshima T et al.Cancer chemopreventive activity of Achyranthes aspera leaves on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis. Cancer Letters. 2002; 177(1): 1-5. DOI: 10.1016/S0304-3835(01)00766-2
52. Misra TN, Singh RS, Pandey HS, Prasad C, Singh BP. Antifungal essential oil and a long chain alcohol from Achyranthes aspera. Phytochemistry. 1992; 31(5): 1811-2. DOI: 10.1016/0031-9422(92)83153-P
53. Elumalai EK, Chandrasekaran N, Thirumalai T, Sivakumar C, Therasa SV, David E. Achyranthes aspera leaf extracts inhibited fungal growth. International Journal of PharmTech Research. 2009; 1(4): 1576-1579.
54. Lee JO, Yang WS, Park JG, Jeong D, Kim HG, Yoon KD,et al. Src and Syk contribute to the anti-inflammatory activities of Achyranthes aspera ethanolic extract. Journal of Ethnopharmacology. 2017; 206: 1-7. DOI: 10.1016/j.jep.2017.05.013
55. Vetrichelvan T, Jegadeesan M. Effect of alcohol extract of Achyranthes aspera Linn. on acute and subacute inflammation. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2003; 17(1): 77-79. DOI: 10.1002/ptr.1070
56. Vijaya Kumar S, Sankar P, Varatharajan R. Anti-inflammatory activity of roots of Achyranthes aspera. Pharmaceutical Biology. 2009; 47(10): 973-5. DOI: 10.1080/13880200902967979
57. Gawande DY, Goel RK. Pharmacological validation of in-silico guided novel nootropic potential of Achyranthes aspera L. Journal of Ethnopharmacology. 201; 175: 324-334. DOI: 10.1016/j.jep.2015.09.025
58. Asif M, Jabeen Q, Atif M, Majid AM, Qamar-Uz-Zaman M. Diuretic activity of achyranthes aspera linn crude aqueous extract in albino rats. Tropical Journal of Pharmaceutical Research. 2014; 13(12): 2039-2045. DOI: vol13_no12/2014_13_12_14.pdf
59. Barua CC, Talukdar A, Begum SA, Borah P, Lahkar M. Anxiolytic activity of methanol leaf extract of Achyranthes aspera Linn in mice using experimental models of anxiety. Indian Journal of Pharmacology. 2012; 44(1): 63-7. DOI: 10.4103/0253-7613.91869
60. Barua CC, Talukdar A, Begum SA, Pathak DC, Sarma DK, Borah RS et al.In vivo wound-healing efficacy and antioxidant activity of Achyranthes aspera in experimental burns. Pharmaceutical Biology. 2012; 50(7): 892-899. DOI: 10.3109/13880209.2011.642885
61. Yadav R, Rai R, Yadav A, Pahuja M, Solanki S, Yadav H. Evaluation of antibacterial activity of Achyranthes aspera extract against Streptococcus mutans: An: in vitro: study. Journal of Advanced Pharmaceutical Technology and Research. 2016; 7(4): 149-52. DOI: 10.4103/2231-4040.191426
62. Alamri, A. M., Alkhilaiwi, F. A., Khan, N. U., and Tasleem, M. (2023). In silico screening and validation of achyranthes aspera as a potential inhibitor of BRAF and NRAS in controlling thyroid cancer. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents), 23(19). 2111-2126. DOI: 10.2174/1871520623666230607125258
63. Beg, M., and Athar, F. (2020). Pharmacokinetic and molecular docking studies of Achyranthes aspera Phytocompounds to exploring potential anti-tuberculosis activity. J Bacteriol Mycol Open Access, 8(1), 18-27.